Literature DB >> 25816835

Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient.

A Ramos1, E Múñez1, J García-Domínguez2, R Martinez-Ruiz3, C Chicharro4, I Baños5, D Suarez-Massa6, V Cuervas-Mons5.   

Abstract

Organ transplant recipients living in endemic regions are at increased risk of Leishmania infections. Visceral leishmaniasis is the most common kind of presentation in the Mediterranean basin. Rarely, Leishmania infantum may cause localized mucosal disease. We present the first case, to our knowledge, of a liver transplant recipient with localized mucosal leishmaniasis. Twenty-two years after transplantation, a painless, very slow growing ulcer appeared on the inner side of the patient's upper lip. A biopsy performed in the community hospital showed non-specific chronic inflammation without neoplastic signs. Because of a high suspicion of malignancy, the patient was transferred to the referral hospital to consider complete excision. The excisional biopsy revealed a granulomatous inflammatory reaction together with intracellular Leishmania amastigotes within macrophages. Leishmaniasis was confirmed by the nested polymerase chain reaction assay. The clinical and laboratory findings did not suggest visceral involvement. The patient received meglumine antimoniate for 21 days without relevant adverse effects.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Leishmania infantum; leishmaniasis; liver transplantation; meglumine antimoniate; mucocutaneous

Mesh:

Substances:

Year:  2015        PMID: 25816835     DOI: 10.1111/tid.12380

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  4 in total

Review 1.  Lip leishmaniasis: a case series with molecular identification and literature review.

Authors:  Iraj Mohammadpour; Mohammad Hossein Motazedian; Farhad Handjani; Gholam Reza Hatam
Journal:  BMC Infect Dis       Date:  2017-01-25       Impact factor: 3.090

2.  Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.

Authors:  Gilles Darcis; Gert Van der Auwera; Jean-Baptiste Giot; Marie-Pierre Hayette; Françoise Tassin; Jorge Arrese Estrada; Lieselotte Cnops; Michel Moutschen; Laurence de Leval; Philippe Leonard
Journal:  BMC Infect Dis       Date:  2017-07-07       Impact factor: 3.090

Review 3.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

Review 4.  New insights into leishmaniasis in the immunosuppressed.

Authors:  Hannah Akuffo; Carlos Costa; Johan van Griensven; Sakib Burza; Javier Moreno; Mercè Herrero
Journal:  PLoS Negl Trop Dis       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.